Therapeutic potential of ginseng in the treatment of allergic respiratory diseases
DOI:
https://doi.org/10.12775/QS.2026.53.69432Keywords
ginseng, asthma, allergic rhinitis, allergic respiratory diseasesAbstract
Introduction and Purpose: Ginseng (Panax spp), known as the king of herbs, is one of the most important medicinal plants in East Asia. Its several thousand years of history in medicine is due to its various therapeutic properties, including immunomodulatory and anticancer properties. The aim of this paper is to present the effects of ginseng use on reducing the symptoms of allergic respiratory diseases, which are becoming increasingly common in the population, as described in scientific studies
State of knowledge: Animal studies have shown that Panax ginseng reduces inflammation of the respiratory tract through its anti-inflammatory and immunomodulatory effects on immune system cells. The effectiveness of black ginseng extract in studies on mice was comparable to that of dexamethasone. Korean red ginseng extract showed similar biological activity, alleviating asthma symptoms and reducing allergic inflammatory reactions in the nose, as well as acting as an antioxidant to reduce inflammation. Human studies have shown that red ginseng extract acts similarly to antihistamines, relieving itching of the nose and eyes, reducing nasal discharge, and reducing nasal congestion. Important medicinal components of the plant are ginsenosides, which can, among other things, reduce the number of inflammatory response cells and suppress cytokine expression, thereby reducing allergy symptoms.
Conclusions: Ginseng shows promising results in the treatment of allergic respiratory diseases by reducing the severity of clinical symptoms and decreasing inflammatory response indicators. It is worth noting that despite good results, further research on a larger group of patients is still needed to confirm its efficacy and safety.
References
Singh AB, Kumar P. Climate change and allergic diseases: An overview. Frontiers in Allergy. 2022;3:964987. https://doi.org/10.3389/FALGY.2022.964987.
Mazur M, Czarnobilska M, Dyga W, Czarnobilska E. Trends in the Epidemiology of Allergic Diseases of the Airways in Children Growing Up in an Urban Agglomeration. J Clin Med. 2022;11(8):2188. https://doi.org/10.3390/JCM11082188.
Wang J, Zhou Y, Zhang H, Hu L, Liu J, Wang L, Zhang H, Cong L, Wang Q. Pathogenesis of allergic diseases and implications for therapeutic interventions. Sig Transduct Target Ther. 2023;8:1-30. https://doi.org/10.1038/S41392-023-01344-4.
Hesse L, Oude Elberink JNG, van Oosterhout AJM, Nawijn MC. Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future. Pharmacology & Therapeutics. 2022;237:108115. https://doi.org/10.1016/j.jgr.2024.04.003.
Shim D, Bak Y, Choi H-G, Lee S, Park S. Effects of Panax Species and their Bioactive Components on Allergic Airway Diseases. Journal of Ginseng Research.2024;48:354-365. https://doi.org/10.1016/j.jgr.2024.04.003.
Huo R, Wang M, Wei X, Qiu Y. Research Progress on Anti-Inflammatory Mechanisms of Black Ginseng. Chem Biodivers. 2023;20(3): e202200846. https://doi.org/10.1002/cbdv.202200846.
Kim JH, Kim JW, Kim CY, Jeong JS, Lim JO, Ko JW, Kim TW. Korean Red Ginseng Ameliorates Allergic Asthma through Reduction of Lung Inflammation and Oxidation. Antioxidants. 2022;11(8):1422. https://doi.org/10.3390/antiox11081422.
Jung JW, Kang HR, Ji GE, Park MS, Song WJ, Kim MH, Kwon JW, Kim TW, Park HW, Cho SH, Min KU. Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res. 2011;3(2):103-10 https://doi.org/10.4168/aair.2011.3.2.103.
Deng SZ, Jalaludin BB, Antó JM, Hess JJ, & Huang CR. Climate change, air pollution, and allergic respiratory diseases: A call to action for health professionals. Chinese Medical Journal. 2022; 133(13):1552–1560. https://doi.org/10.1097/CM9.0000000000000861.
Brusselle GG, Koppelman GH. Biologic Therapies for Severe Asthma. New England Journal of Medicine. 2022; 386(2): 157–171. https://doi.org/10.1056/NEJMRA2032506.
Habib N, Pasha MA, Tang DD. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022; 11(17): 2764. https://doi.org/10.3390/CELLS11172764.
Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis C. Immunologic mechanisms in asthma. Seminars in Immunology. 2019; 46: 101333. https://doi.org/10.1016/J.SMIM.2019.101333.
Choi JP, Kim YS, Kim OY, Kim YM, Jeon SG, Roh TY, Park JS, Gho YS, Kim YK. TNF-alpha is a key mediator in the development of Th2 cell response to inhaled allergens induced by a viral PAMP double-stranded RNA. Allergy. 2012; 67(9): 1138–1148. https://doi.org/10.1111/J.1398-9995.2012.02871.X.
Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology. 2022; 77(11): 3309–3319. https://doi.org/10.1111/ALL.15454
2023 GINA Main Report - Global Initiative for Asthma - GINA. https://ginasthma.org/2023-gina-main-report/
Ikuta K., Ejima A, Abe S, Shimba A. Control of immunity and allergy by steroid hormones. Allergology International. 2022; 71(4): 432–436. https://doi.org/10.1016/j.alit.2022.07.006.
Yang A, Yu G, Wu Y, Wang H. Role of β2-adrenergic receptors in chronic obstructive pulmonary disease. Life Sciences. 2021; 265: 118864. https://doi.org/10.1016/J.LFS.2020.118864.
Matera MG, Cazzola M, Rogliani P, Patella V. An update on long-acting muscarinic agents for asthma therapy. Expert Review of Respiratory Medicine. 2025; 19(5): 407-421. https://doi.org/10.1080/17476348.2025.2484289;REQUESTEDJOURNAL:JOURNAL:IERX20;SUBPAGE:STRING:ACCESS.
Pawliczak R. Role of montelukast in asthma treatment in 2025. Alergologia Polska - Polish Journal of Allergology. 2025; 12(1): 42–45. https://doi.org/10.5114/PJA.2025.147954.
Lisiecka MZ. Evolution, mechanism of action, and clinical applications of three generations of Antihistamines. Innovaciencia. 2024; 12(1). https://doi.org/10.15649/2346075X.3651.
Ma LJ, Liu X, Guo L, Luo Y, Zhang B, Cui X, Yang K, Cai J, Liu F, Ma N, Yang FQ, He X, Shi SP, Wan JB. Discovery of plant chemical defence mediated by a two-component system involving β-glucosidase in Panax species. Nature Communications. 2024;15(1). https://doi.org/10.1038/s41467-024-44854-7.
Zeng T, Pei J, Miao Y, Zheng Y, Gu S, Zhao L, Huang L. Current Status and Research Trends of Panax Between 1900–2019: A Bibliometric Analysis. Chinese Journal of Integrative Medicine. 2022;28(6):547-553. https://doi.org/10.1007/s11655-021-3315-8.
Liu L, Xu FR Wang YZ. Traditional uses, chemical diversity and biological activities of Panax L. (Araliaceae): A review. Journal of Ethnopharmacology. 2023;263:112792. https://doi.org/10.1016/j.jep.2020.112792.
Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, Cho JY. Pharmacological potential of ginseng and its major component ginsenosides. Journal of Ginseng Research. 2021;45:199-210. https://doi.org/10.1016/j.jgr.2020.02.004.
Park SK, Hyun SH, In G, Park CK, Kwak YS, Jang YJ, Kim B, Kim JH, Han CK. The antioxidant activities of Korean Red Ginseng (Panax ginseng) and ginsenosides: A systemic review through in vivo and clinical trials. Journal of Ginseng Research. 2021;45(1):41-47. https://doi.org/10.1016/j.jgr.2020.09.006.
You L, Cha S, Kim MY, Cho JY. Ginsenosides are active ingredients in Panax ginseng with immunomodulatory properties from cellular to organismal levels. Journal of Ginseng Research. 2022;46(6):711-721. https://doi.org/10.1016/j.jgr.2021.12.007.
Song Y, Chen C, Li W. Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms. Chinese Herbal Medicines. 2024;16(4):489-504. https://doi.org/10.1016/j.chmed.2024.09.006.
Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, Cui X, Cao H, Zhang X, Han C. Ginsenosides: A Potential Neuroprotective Agent. BioMed Research International. 2018;1:8174345. https://doi.org/10.1155/2018/8174345.
Kim DY, Yang WM. Panax ginseng ameliorates airway inflammation in an ovalbumin-sensitized mouse allergic asthma model. Journal of Ethnopharmacology. 2011;136(1):230–235. https://doi.org/10.1016/J.JEP.2011.04.048.
Jin Y, Kim YJ, Jeon JN, Wang C, Min JW, Noh HY, Yang DC. Effect of white, red and black ginseng on physicochemical properties and ginsenosides. Plant Foods for Human Nutrition. 2015;70(2):141–145. https://doi.org/10.1007/s11130-015-0470-0.
Song YN, Lee JW, Ryu HW, Lee JK, Oh ES, Kim DY, Ro H, Yoon D, Park JY, Hong ST, Kim MO, Lee SU, Lee DY. Black Ginseng Extract Exerts Potentially Anti-Asthmatic Activity by Inhibiting the Protein Kinase Cθ-Mediated IL-4/STAT6 Signaling Pathway. International Journal of Molecular Sciences. 2023;24(15):11970. https://doi.org/10.3390/ijms241511970.
Lee DK, Park S, Long NP, Min JE, Kim HM, Yang E, Lee SJ, Lim J, Kwon SW. Research Quality-Based Multivariate Modeling for Comparison of the Pharmacological Effects of Black and Red Ginseng. Nutrients. 2020;12(9):2590. https://doi.org/10.3390/NU12092590.
Jung JH, Kang IG, Kim DY, Hwang YJ, Kim ST. The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis. Journal of Ginseng Research. 2013;37(2):167–175. https://doi.org/10.5142/jgr.2013.37.167.
Jung JH, Kang TK, Oh JH, Jeong JU, Ko KP, Kim ST. The Effect of Korean Red Ginseng on Symptoms and Inflammation in Patients With Allergic Rhinitis. Ear, Nose and Throat Journal. 2021;100(5S):712-719. https://doi.org/10.1177/0145561320907172.
Huang WC, Huang TH, Yeh KW, Chen YL, Shen SC, Liou CJ. Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice. Journal of Ginseng Research. 2021;45(6):654-664. https://doi.org/10.1016/j.jgr.2021.03.002.
Lee IS, Uh IJ, Kim KS, Kim KH, Park J, Kim Y, Jung JH, Jung HJ, Jang HJ. Anti-Inflammatory Effects of Ginsenoside Rg3 via NF- κ B Pathway in A549 Cells and Human Asthmatic Lung Tissue. Journal of Immunology Research. 2016;7521601:1–11. https://doi.org/10.1155/2016/7521601.
Kim HI, Kim JK, Kim JY, Han MJ, Kim DH. Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression. Journal of Ginseng Research. 2019;43(4): 635–644. https://doi.org/10.1016/j.jgr.2019.02.006.
Liu T, Zhang R, Jiang L, Zhou L, Zhang H, Liang F, Xiong P, Chen H, Wen T, Shen X, Xie C, Tian L. The potential application and molecular mechanisms of natural products in the treatment of allergic rhinitis: A review. Phytomedicine. 2024;129: 155663. https://doi.org/10.1016/j.phymed.2024.155663.
Niu C, Liu N, Liu J, Zhang M, Ying L, Wang L, Tian D, Dai J, Luo Z, Liu E, Zou L, Fu Z. Vitamin A maintains the airway epithelium in a murine model of asthma by suppressing glucocorticoid‐induced leucine zipper. Clinical & Experimental Allergy. 2016;46(6):848–860. https://doi.org/10.1111/cea.12646.
Yang L, Xu M, Zhang L, Zhang M, Wu W, Luo Z, Tian D, Fu Z, Zou W. Panax notoginseng saponin R1 improves glucocorticoid-inhibited airway epithelium repair via glucocorticoid receptor β”. International Immunopharmacology. 2024;127: 111347. https://doi.org/10.1016/j.intimp.2023.111347.
Xue K, Ruan L, Hu J, Fu Z, Tian D, Zou W. Panax notoginseng saponin R1 modulates TNF-α/NF-κB signaling and attenuates allergic airway inflammation in asthma. International Immunopharmacology. 2020;88:106860. https://doi.org/10.1016/j.intimp.2020.106860.
Zhang Y, Song Y, Wang C, Jiang J, Liu S, Bai Q, Li L, Jin H, Jin Y, Yan G. Panax notoginseng saponin R1 attenuates allergic rhinitis through AMPK/Drp1 mediated mitochondrial fission. Biochemical Pharmacology. 2022;202:15106. https://doi.org/10.1016/j.bcp.2022.115106.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Wiktoria Szewczyk, Gabriela Żychowska, Florian Sowa, Magdalena Dederko, Justyna Drapała, Kamil Mucha, Krzysztof Gomułka

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 84
Number of citations: 0